Sompo appoints Nicholas Walsh as Independent Non-Executive Chairman of the Board of Directors for Sompo International Holdings Ltd. Notified -
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy Notified -
Ingredion Incorporated Reports Strong First Quarter Results and Improves Full-Year Outlook Notified -
SiriusPoint reports tenth consecutive quarter of underwriting profits and strong net income of $58m Notified -
BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives [img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=06e03d9e-e70a-4534-af08-010615a35e55&size=0[/img]Notified -
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab) Notified -
Bitget Amplifies Global Leadership and Community Impact with Strong Presence at TOKEN2049 Dubai Notified -